Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | 91.16 JPY | -55.38% |
| 2023 | 204.29 JPY | 38.84% |
| 2022 | 147.14 JPY | -38.88% |
| 2021 | 240.72 JPY | 747.31% |
| 2020 | 28.41 JPY | -49.94% |
| 2019 | 56.75 JPY | -52.58% |
| 2018 | 119.67 JPY | 62.64% |
| 2017 | 73.58 JPY | 43.91% |
| 2016 | 51.13 JPY | 155.16% |
| 2015 | -92.69 JPY | -237.22% |
| 2014 | 67.55 JPY | -28.22% |
| 2013 | 94.11 JPY | 19.66% |
| 2012 | 78.65 JPY | -49.91% |
| 2011 | 157.01 JPY | -16.75% |
| 2010 | 188.60 JPY | 30.15% |
| 2009 | 144.91 JPY | -30.83% |
| 2008 | 209.49 JPY | 8.54% |
| 2007 | 193.00 JPY | 9.2% |
| 2006 | 176.74 JPY | 12.93% |
| 2005 | 156.51 JPY | -2.75% |
| 2004 | 160.93 JPY | 4.62% |
| 2003 | 153.82 JPY | 15.21% |
| 2002 | 133.51 JPY | 60.47% |
| 2001 | 83.20 JPY | 22.75% |
| 2000 | 67.78 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 57.51 JPY | 3261.98% |
| 2024 Q3 | 67.38 JPY | 319.62% |
| 2024 FY | - JPY | -54.92% |
| 2024 Q4 | -1.92 JPY | -102.85% |
| 2024 Q2 | -30.68 JPY | -4.23% |
| 2023 Q1 | 67.92 JPY | 1027.87% |
| 2023 Q3 | 76.63 JPY | 92.68% |
| 2023 FY | - JPY | 38.84% |
| 2023 Q4 | 20.03 JPY | -73.86% |
| 2023 Q2 | 39.77 JPY | -41.45% |
| 2022 FY | - JPY | -38.88% |
| 2022 Q3 | 36.90 JPY | 26.2% |
| 2022 Q1 | 87.96 JPY | -30.15% |
| 2022 Q4 | -7.32 JPY | -119.84% |
| 2022 Q2 | 29.24 JPY | -66.76% |
| 2021 Q2 | 2.58 JPY | -95.13% |
| 2021 Q3 | 59.08 JPY | 2189.92% |
| 2021 Q4 | 125.92 JPY | 113.13% |
| 2021 FY | - JPY | 747.31% |
| 2021 Q1 | 52.94 JPY | 4712.73% |
| 2020 Q1 | -13.29 JPY | 64.06% |
| 2020 Q3 | -20.68 JPY | -147.56% |
| 2020 Q4 | 1.10 JPY | 105.32% |
| 2020 FY | - JPY | -49.94% |
| 2020 Q2 | 43.48 JPY | 427.16% |
| 2019 Q3 | 24.07 JPY | -22.03% |
| 2019 Q4 | -36.98 JPY | -253.64% |
| 2019 FY | - JPY | -52.58% |
| 2019 Q2 | 30.87 JPY | -38.3% |
| 2019 Q1 | 50.03 JPY | 244.85% |
| 2018 Q2 | 17.95 JPY | -80.66% |
| 2018 FY | - JPY | 62.64% |
| 2018 Q4 | -34.54 JPY | -179.24% |
| 2018 Q3 | 43.59 JPY | 142.84% |
| 2018 Q1 | 92.81 JPY | 385.39% |
| 2017 Q1 | 63.65 JPY | 397.29% |
| 2017 FY | - JPY | 43.91% |
| 2017 Q4 | -32.52 JPY | -222.72% |
| 2017 Q3 | 26.50 JPY | 67.09% |
| 2017 Q2 | 15.86 JPY | -75.08% |
| 2016 Q1 | 15.66 JPY | 110.9% |
| 2016 FY | - JPY | 155.16% |
| 2016 Q3 | 37.82 JPY | 98.84% |
| 2016 Q2 | 19.02 JPY | 21.46% |
| 2016 Q4 | -21.41 JPY | -156.61% |
| 2015 Q3 | 11.65 JPY | -34.7% |
| 2015 FY | - JPY | -237.22% |
| 2015 Q4 | -143.66 JPY | -1333.13% |
| 2015 Q2 | 17.84 JPY | -15.85% |
| 2015 Q1 | 21.20 JPY | 870.91% |
| 2014 Q2 | 27.11 JPY | 19.06% |
| 2014 Q3 | 34.53 JPY | 27.37% |
| 2014 Q4 | -2.75 JPY | -107.96% |
| 2014 FY | - JPY | -28.22% |
| 2014 Q1 | 22.77 JPY | 568.52% |
| 2013 Q4 | -4.86 JPY | -140.13% |
| 2013 FY | - JPY | 19.66% |
| 2013 Q1 | 55.46 JPY | 340.29% |
| 2013 Q2 | 20.41 JPY | -63.2% |
| 2013 Q3 | 12.11 JPY | -40.67% |
| 2012 Q1 | 47.88 JPY | 133.45% |
| 2012 Q4 | -23.08 JPY | -246.08% |
| 2012 Q3 | 15.80 JPY | -58.48% |
| 2012 Q2 | 38.05 JPY | -20.53% |
| 2012 FY | - JPY | -49.91% |
| 2011 Q4 | 20.51 JPY | -54.57% |
| 2011 Q1 | 40.61 JPY | 66.09% |
| 2011 Q2 | 50.74 JPY | 24.94% |
| 2011 Q3 | 45.15 JPY | -11.02% |
| 2011 FY | - JPY | -16.75% |
| 2010 FY | - JPY | 30.15% |
| 2010 Q3 | 44.03 JPY | -9.77% |
| 2010 Q2 | 48.80 JPY | -31.58% |
| 2010 Q4 | 24.45 JPY | -44.47% |
| 2010 Q1 | 71.32 JPY | 71.07% |
| 2009 Q4 | 41.69 JPY | -23.39% |
| 2009 FY | - JPY | -30.83% |
| 2009 Q2 | 38.96 JPY | 0.0% |
| 2009 Q3 | 54.42 JPY | 39.68% |
| 2008 FY | - JPY | 8.54% |
| 2007 FY | - JPY | 9.2% |
| 2006 FY | - JPY | 12.93% |
| 2005 FY | - JPY | -2.75% |
| 2004 FY | - JPY | 4.62% |
| 2003 FY | - JPY | 15.21% |
| 2002 FY | - JPY | 60.47% |
| 2001 FY | - JPY | 22.75% |
| 2000 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | -0.48 USD | 19091.667% |
| Bausch Health Companies Inc. | -1.62 USD | 5727.16% |
| Catalent, Inc. | -5.76 USD | 1682.639% |
| Emergent BioSolutions Inc. | -14.85 USD | 713.872% |
| Elanco Animal Health Incorporated | -2.50 USD | 3746.4% |
| Perrigo Company plc | -0.09 USD | 97182.002% |
| Teva Pharmaceutical Industries Limited | -0.50 USD | 18332.0% |
| Zoetis Inc. | 5.08 USD | -1694.488% |